Sponsor pipeline

Galimedix Therapeutics Inc clinical trial pipeline

2 active trials 1 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-05

What changed in the last 30 days

2026-08-15

Trial sites expanded: 20 → 25 locations

NCT06659549 A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal… · Phase 2

2026-08-07

Trial sites expanded: 14 → 20 locations

NCT06659549 A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal… · Phase 2

First posted	Trial	Phase	Status
2026-08-27	NCT07789873 A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease	Phase 2	Not Yet Recruiting
2026-08-21	NCT07780604 A SINGLE CENTER, 5-PART STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY AND…	Phase 1	Completed

Phase 2

NCT ID	Title	Condition	Status	Updated
Phase 2
NCT06659549	A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal…	Geographic Atrophy of the Macula	Recruiting	2026-08-20
NCT07789873	A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease	Mild to Moderate Alzheimer's Disease	Not Yet Recruiting	2026-08-27

Get alerts when Galimedix Therapeutics Inc's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.